Jake Keck Named VP Engineering & Service Operations at Tenacore LLC

mJOULE Launches in the United Kingdom Reports Sciton

"Sciton is dedicated to worldwide support and growth. We continue to demonstrate our commitment to developing high quality devices and marketing efforts for our physician and medspa partners worldwide." says Lacee J. Naik, Vice President of Marketing and Public Relations.

FDA Issues Draft Guidance on Remanufacturing and Discussion Paper Seeking Feedback on Cybersecurity Servicing of Medical Devices

With this in mind, the FDA is issuing today's draft guidance to help clarify whether activities performed on medical devices are likely remanufacturing as well as a discussion paper on cybersecurity servicing of devices.

Irrimax Receives FDA Clearance for Irrisept

"This new clearance from the FDA further solidifies Irrisept as the market leader in wound irrigation," said Mark Alvarez, CEO of Irrimax.

June 26, 2020

Jake Keck has been named the new Vice President of Engineering & Service Operations at Tenacore, LLC. 

Jake Keck will lead the operations and quality teams in the implementation of a new service operating model and quality management system. Keck will serve as a member of the Tenacore executive leadership team reporting to CEO James Willett.

Keck’s team is responsible for daily service and repair operations, in addition to the quality function.  Jake’s team will be leading the company’s transition to a new service operations management platform, enabling Tenacore to reengineer current service and repair processes and transform service line capabilities. The transition to T-Connect will position Tenacore with best-in-class service and repair systems infrastructure, allowing customers to better manage asset repair costs.

“Jake is an outstanding addition to the Tenacore team, bringing a diverse base of experience in medical product design and operations leadership that will enable Tenacore to broaden and strengthen core service and repair capabilities,” says James Willett, CEO. Jake is the final addition to the new senior management team recruited to Tenacore to grow its focus in the service and repair of healthcare technology. Other senior leadership team members include Barbara Bitzer, CFO; Brandon Anaya, VP of Sales and Marketing; and Willett, the new CEO for Tenacore as of February 2020.

Keck most recently served as senior director of research and development with Vyaire Medical. He was responsible for new product development and design control of capital equipment. Jake has served as director of operations for Spectranetics (now Philips) Specialty & Drug-Coated Catheters where he led an operations team of over 60 for the launch of the company’s next-generation drug-coated catheter. He was responsible for launch planning, pipeline fill, capacity, resource, and contingency planning. Jake also held multiple research and development roles with Medtronic and Covidien.

“I am excited to join the leadership team at Tenacore and lead the operations and quality organizations as we expand the company into a leading force in the medical equipment service depot market,” said Keck. “This role provides an opportunity to apply a range of engineering and quality practices that are commonplace in the OEM market and make certain they are part of our standard operating practices at Tenacore. We want to ensure we are delivering for our customers and the patients they serve each day.”

Keck earned a BS in Mechanical Engineering Technology from Purdue University in West Lafayette, IN.

spot_img

DON'T MISS

Hyperfine Adds Medtech Leader and Visionary Scott Huennekens as Executive Chairman

Mr. Huennekens’ public boards include Chairman of Acutus Medical (IPO August 2020); Chairman of Envista (IPO September 2019); and board member of Nuvasive. He also serves as a board member and past Chairman of the Medical Device Manufacturer’s Association (MDMA).

One Drop Reports Carrie Siragusa, CPA Appointed VP of Commercial Strategy, Biosensor

Formerly Head of Innovation and Diabetes Portfolio at Sanofi, Siragusa will be part of a team bringing a multi-analyte dermal sensor (biosensor) with continuous health sensing capabilities to market with a mission to provide broader access to continuous glucose monitoring.

Barbara Moorhouse Appointed as Medica Non-Executive Director

Barbara has extensive business and management experience in the private, public, and regulated sectors.

Subscribe to Medical Device News Magazine here.

Related Articles

Join our list

Subscribe to our mailing list and receive an end-of-week recap news and updates delivered right to your email inbox.